News | September 12, 2024
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
Read More
Press Release | September 3, 2024
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
Read More
Press Release | August 14, 2024
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
Read More
Press Release | July 24, 2024
Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
Read More
